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T lymphocytes are critical effectors in the pathogenesis
of contact hypersensitivity. Nickel is the most common
contact sensitizer in humans and nickel-specific CD4F T
helper cells have been extensively characterized. Because
recent observations have suggested the activation of
CD8F T cells in murine models of contact hyper-
sensitivity, we investigated the existence of CD8F hapten-
specific T lymphocytes in patients with allergy to nickel.
Nickel-specific T cell lines were generated from the
peripheral blood of three allergic donors. The T cell lines
were composed of a majority of CD4F T cells, but CD8F
T cells were also present and their percentage increased
with repeated in vitro stimulations. In addition to nickel-
reactive helper T cell-0-type or helper T cell-2-type
CD4F T cell clones, CD8F T cell clones could be derived
from these cell lines and a total of 15 clones were
further studied. Cytokine production was evaluated for
Contact hypersensitivity (CHS) reaction is a skin diseaseinvolving the proliferation of T cells in response to lowmolecular weight compounds. Nickel represents themost common contact sensitizer in humans with about10% of the Caucasian population sensitized (Basketter
et al, 1993). An abundant literature is available on nickel-induced CHS
reactions including the characterization of nickel-specific T cells isolated
from either peripheral blood or skin lesions of sensitized patients. Such
cells mainly belong to the CD41 subset and are major histocompatibility
complex (MHC) class II restricted (Sinigaglia et al, 1985; Kapsenberg
et al, 1987, 1988; Silvennoinen-Kassinen et al, 1991). They have been
characterized in terms of MHC restriction, processing requirements
(Moulon et al, 1995), and cytokine production (Kapsenberg et al, 1992;
Probst et al, 1995; Werfel et al, 1997). Very little information is available
concerning the nature of the antigenic determinants recognized by
nickel-specific human T cells. Current data suggest that nickel-modified
self peptides presented by MHC class II molecules might be reponsible
for the activation of nickel-specific T cells (Romagnoli et al, 1991;
Emtestam and Olerup, 1996), but the actual antigenic determinants
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11 CD8F T cell clones that were either cytotoxic T cell-
0- or cytotoxic T cell-1-type clones. Additional effector
functions were investigated on the complete panel of T
cell clones. These CD8F T cells did not only display
hapten-specific proliferation, but also specific cytotoxic
activities towards autologous EBV-B cells in the presence
of nickel. Two different types of CD8F T cells were
characterized. Most of the clones lysed only autologous
targets in the constant presence of nickel; however, one
clone was able to lyse numerous targets in the presence
of NiSO4, irrespective of the expression of either major
histocompatibility complex class I or class II molecules.
The characterization of nickel-specific cytotoxic CD8F
T cells with different requirements for nickel-specific
target lysis, may have important implications in the
development or in the control of human contact hyper-
sensitivity reactions to nickel in vivo. Key words: contact
hypersensitivity/cytokines. J Invest Dermatol 111:360–366, 1998
recognized by nickel-activated T cells remain to be identified. No
preferential HLA association has been found in subjects allergic to
nickel (Emtestam et al, 1993); however, skewing of the nickel-reactive
TCR repertoire has been reported (Vollmer et al, 1997; Werfel
et al, 1997).
The originally postulated effector role of CD41 T cells in CHS
reactions (Hauser, 1990; Kondo et al, 1996) has been recently challenged
in different mouse models of this disease. In several systems, hapten-
specific CD81 T cells have been described as mediators of CHS
reactions, whereas CD41 T cells were shown to be regulators of the
inflammatory reaction (Gocinski and Tigelaar, 1990; Anderson et al,
1995; Bour et al, 1995; Xu et al, 1996).
CD81 hapten-specific T cells have also been described in human
CHS reactions (Kalish, 1990; Hertl et al, 1993); however, although
CD81 T cells specific for nickel have been occasionally mentioned in
different reports, no detailed studies on CD81 human nickel-specific
T cell clones have been conducted. The aim of this study was thus to
investigate the presence of and the activation requirements of nickel-
specific CD81 human T lymphocytes.
MATERIALS AND METHODS
Patients Three nickel allergic donors participated in this study after giving
informed consent. Nickel allergy was evaluated according to the standard
procedure using epicutaneous application of NiSO4.6H2O at 5% in vaseline
using the Finn chamber method. All patch test areas were read at days 2 and 3
after application. The HLA haplotypes of the donors were as follows: donor
AE [HLA-A28, B27, B55(22), Cw2, Cw9(3), DR13(6), DR15(2), DR51,
DR52, DQ6(1)], donor CM [HLA-A1, A29(19), B8, Cw7, DR15(2), DR17(3),
DR51, DR52, DQ2, DQ6(1)], donor IF [HLA-A1, A66(10), B35, B53, Cw4,
DR4, DR13(6), DR52, DR53, DQ6(1), DQ7(3)].
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Metal salts and culture media The concentrations of each metal salt used
in culture were as follows: NiSO4.6H2O, 10
–4–2.5 3 10–5 M; CoCl2.6H2O,
5 3 10–5–7.5 3 10–6 M; PdCl2, 5 3 10
–4–7.5 3 10–5 M; CuSO4.5H2O,
10–5–2.5 3 10–6 M; K2Cr2O7, 10
–7–2.5 3 10–8 M; and ZnSO4.7H2O,
7.5 3 10–6–10–7 M (all obtained from Sigma, Deisenhofen, Germany). For
each metal, nontoxic ranges of concentrations were defined as those that did
not affect a PHA-induced proliferation of peripheral blood mononuclear cells
(PBMC) from nonallergic donors (data not shown). Stock solutions were stored
at –20°C. The culture medium was RPMI 1640 supplemented (all from Gibco
BRL, Eggenstein, Germany) with 2 mM L-glutamine, 100 µg kanamycin per
ml, 5 3 10–5 M 2-mercaptoethanol, 1 mM sodium pyruvate, 13mixture of
nonessential amino-acids, and 5% pooled human AB serum (RPMI-HS) or
10% heat-inactivated fetal calf serum (RPMI-FCS). To support the antigen-
independent growth of T cell clones, this medium was supplemented with
100 U recombinant human IL-2 per ml (Eurocetus, Ratingen, Germany).
Nickel-specific T cell lines and clones PBMC (106 per ml) isolated by
Ficoll-Hypaque (Pharmacia, Freiburg, Germany) were cultivated in vitro with
10–4 M NiSO4 in RPMI-HS for 7 d in a final volume of 5 ml in 6 well culture
plates. Cells were then washed and expanded in IL-2-containing RPMI-HS
for another 5 d. These lines were stimulated a second time with the hapten
and irradiated (3000 rads) autologous PBMC (106 per ml) and, after 3 d,
expanded again by adding IL-2. In some cases, T cell lines were further
stimulated using the same procedure. T cell clones were generated from these
nickel-specific T cell lines after the second stimulation of PBMC by the
sensitizing hapten. For cloning, T cell blasts were seeded at 0.3 cells per well
in Terasaki plates (Nunc, Wiesbaden, Germany) in the presence of 1 µg PHA-
P per ml (Murex Diagnostics, Dartford, U.K.), 100 U IL-2 per ml, and 104
irradiated allogeneic fresh PBMC. The obtained T cell clones were expanded
and maintained in culture by periodic stimulation in the presence of irradiated
allogeneic PBMC, PHA, and IL-2. The CD41 clones reported here are all
specific for NiSO4, but some of them (called HSA.Ni clones) were induced
using nickel-modified human serum albumin (HSA) as previously reported
(Vollmer et al, 1997). The other T cell clones were all induced using NiSO4.
Antigen-presenting cells PBMC and autologous EBV-transformed B cell
lines (EBV-B cells) were used as antigen-presenting cells (APC). Sweig 007
[B cell line IHW 9037 with the following HLA haplotype: HLA-A29(19),
B61(40), Cw2, DR11(5), DR52, DQ7(3)], and T2 cell lines were obtained
from Dr. P. Cresswell (Howard Hughes Medical University, New Haven, CT)
(Newcomb and Cresswell, 1993). Jesthom is a DR1 homozygous B cell line
(IHW 9004). The 721.221 cell line was obtained from Dr. P. van Endert
(INSERM, Paris, France) (Shimizu and DeMars, 1989). For immortalization
of B cells, PBMC (107) were resuspended in 10 ml RPMI-FCS containing
30% supernatant of the EBV-producing marmoset cell line B95–8 [American
Type Culture Collection (ATCC)] and 600 ng cyclosporine A per ml (Sandoz,
Basel, Switzerland). After incubation overnight, cells were washed and cultured
in RPMI-FCS.
Proliferation assays T cells (2 3 104) were cocultured in triplicate with
2 3 104 irradiated (3000 rads) PBMC or irradiated (6000 rads) EBV-B cells in
200 µl of RPMI-FCS with the different metal salts, without hapten or with
25 µg peptide HA307–319 per ml. After 48 h, cultures were pulsed with
[3H]thymidine and incorporation was measured after another 18 h. Triplicates
were harvested on GF/A-filters and the isotope incorporation was measured in
an automatic β-counter (Inotech, Asbach, Germany). In some experiments,
APC were fixed as described by Shimonkevitz et al (1983). Briefly, EBV-B cells
were resuspended in medium without serum and fixed in 0.05% glutaraldehyde
for 45 s at room temperature. The reaction was stopped by adding 1 ml of
0.2 M L-Lysine for an additional 45 s. Cells were then washed and in some
experiments pulsed for 90 min at 37°C with the hapten and washed again
before being used as APC as described above. A DR1-restricted T cell clone
(12F), specific for the hemagglutinin peptide HA307–319 (PKYVKQNTLK-
LAT), was used as positive control.
Cytotoxic assays EBV-B cells were used as targets in a standard 4 h 51Cr-
release assay. Briefly, targets were labeled with Na2
51CrO4 (NEN Life Science
Products, Boston, MA) for 90 min at 37°C and extensively washed. The
number of target cells was maintained constant (2 3 103 cells per 200 µl) and
effector cells were used at effector:target ratios between 30:1 and 1:1 in RPMI-
FCS. NiSO4 (10
–4 M) or PHA (1 µg per ml) were added to the round-
bottom microwells at fixed concentrations if not otherwise indicated. In some
experiments, target cells were pulsed for 90 min at 37°C with the hapten and
washed before addition to the effector cells. After 4 h, 51Cr-release in the
supernatants was measured in triplicate in an automatic γ-counter (Packard,
Dreieich, Germany). Specific lysis was calculated according to Shearer (1974).
All data represent the mean of triplicates with SD , 10%.
Flow cytometry Mouse monoclonal antibodies used for flow cytometry
were as follows: CD4 (13B8.2, Immunotech, Krefeld, Germany), CD8 (B9.11,
Immunotech), TcR Panα/β (BMA031, Immunotech), and anti-DR (L243,
ATCC). The rat monoclonal antibody HECA-452 against the cutaneous-
associated-antigen (CLA) was kindly provided by Dr. L.J. Picker (University of
Texas Southwestern Medical Center, Dallas, TX) (Picker et al, 1990). Fluoroscein
isothiocyanate-conjugated goat anti-mouse IgG 1 M (H 1 L) and PE-
conjugated goat anti-rat IgM were purchased from Jackson ImmunoResearch
Laboratories (West Grove, PA). T cells were stained at 4°C in 96 well plates
(2 3 105 per well) with monoclonal antibody and fluoroscein isothiocyanate-
or PE-conjugated secondary antibody. Fluorescence was measured in a FACScan
instrument (Becton Dickinson, San Jose, CA).
Cytokine assays Cloned T cells (2 3 105) were cocultured in
triplicate with 105 irradiated (6000 rads) autologous EBV-B cells in
200 µl of RPMI-HS with or without hapten. After 48 h, culture
supernatants were used to measure IFNγ and IL-4 production by
enzyme-linked immunosorbent assays (Rogge et al, 1997).
RESULTS
In vitro culture of PBMC with NiSO4 stimulates both CD4
F
and CD8F cells and CD8F T cell number increases with the
number of antigenic stimulations In order to investigate the
nature of the T cells activated by NiSO4, PBMC from three donors,
whose allergy to nickel was assessed by positive epicutaneous reactions
to this metal, were cultivated in vitro in the presence of NiSO4.
Activated T cells were expanded after 1 wk by addition of IL-2 and
the phenotype of the cell lines was investigated by fluorescence-
activated cell sorter analysis. In all three cases we found more CD41
T cells (74%–92%) than CD81 T cells (6%–17%) after the first
in vitro antigenic stimulation. When these T cell lines were stimulated
repeatedly with NiSO4 and autologous PBMC, we found that the
fraction of CD81 cells increased to values of 35%–60% of the total T
cells (Fig 1a). The nickel-specificity of these cell lines was tested by
proliferation assays and representative data are shown for donor IF in
Fig 1(b). T cells alone proliferated weakly in response to nickel in the
absence of APC. This could be explained by the expression of MHC
class I and II molecules by human T cells that might allow them to
act as APC (Barnaba et al, 1994); however, antigenic stimulation was
greatly enhanced by addition of APC (either autologous PBMC or
EBV-B cells). Figure 1(c) shows an exemplary phenotypic analysis of
these activated T cells expressing an αβTcR and MHC class II
molecules and in this particular case comprising 20% of CD81 cells.
In order to characterize the CD81 populations, T cell clones were
produced from T cell lines generated from donors IF, CM, and AE
after the second in vitro stimulation.
Nickel-specific CD8F T cell clones display both proliferative
capacities and specific cytotoxic activities The majority of the
T cell clones isolated from three different cell lines were again from
the CD41 subset; however, for each donor, CD81 T cell clones could
be derived (three of 35 from donor IF, one of 16 from donor CM,
and one of six from donor AE). A new cloning procedure was
performed from two other nickel-specific T cell lines of donor IF,
providing 10 additional CD81 T cell clones. All tested T cell clones
were positive for CLA expression as reported in Table I. All CD81
T cell clones were CD4– and TcRαβ1 as shown for two representative
clones, L1.1 and 3.3, in Fig 2(a). The T cell clones were specific for
nickel, and responded to the antigen as evaluated by different effector
functions. As shown in Fig 2(b), they proliferated after addition of
NiSO4 in the presence of EBV-B cell lines. Clone 3.3 exhibited a
weak cross-reaction to Pd (Fig 1b), but no additional metal reactivities
could be detected. As one of the characteristics of CD81 T cells is
their cytotoxic potential, we investigated whether nickel-specific CD81
T cell clones were cytolytic. We utilized both a nonantigen specific
stimulus, the PHA lectin, and an antigen-specific stimulation with
NiSO4. As shown in Fig 2(c), CD8
1 nickel-specific T cell clones,
indeed, lysed autologous B cells in the presence of nickel salts, or in
the presence of PHA, but not in their absence. The cross-reactivity of
Clone 3.3 towards Pd also occurred in cytotoxic assays (data not shown).
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Figure 1. In vitro culture of PBMC with
NiSO4 stimulates both CD4
F and CD8F
cells and CD8F T cell number increases
with the number of antigenic stimulations.
Hapten-specific T cell lines were produced by
in vitro stimulation of PBMC from three nickel-
allergic donors with NiSO4. (a) Percentages of
CD41 versus CD81 T cells were assessed in
nickel-specific T cell lines generated from three
allergic donors, after one, two, or three rounds
of in vitro stimulation with irradiated autologous
PBMC and NiSO4. nd, not determined. (b)
Nickel-specificity of a T cell line from donor
IF was assessed by stimulation with NiSO4
without APC, with irradiated autologous
PBMC, or with EBV-B cell lines. The
proliferative response was determined by
incorporation of [3H]thymidine in triplicate and
is expressed in cpm 6 SD. Representative data
are shown for a nickel-specific T cell line after
the second in vitro stimulation. (c) CD4, CD8,
HLA-DR, and αβTcR phenotypes of the
nickel-specific T cell lines were investigated by
fluorescence-activated cell sorter analysis and
the percentages of CD41 and CD81 T cells
were determined. Black histograms represent
the staining with the appropriate antibody and
white histograms represent the isotype control.
Results are shown for a representative cell line
from donor IF.
CD8F T cell clones produce cytotoxic T cell (TC)-1-type
cytokines, whereas CD4F T cell clones are helper T cell
(TH)-2-type T cells The cytokine profile of a total of 11 CD81
independent nickel-specific T cell clones isolated from the peripheral
blood of donor IF was studied. For comparison, CD41 T cell clones
originating from NiSO4- and HSA-Ni-induced T cell lines of the
same donor, or from NiSO4-induced T cell lines of the two other
donors, were also included in the assay. In all cases, IL-4 and IFNγ
production were determined following activation by NiSO4 in the
presence of autologous EBV-B cells. The data are summarized in
Table I. All CD41 T cell clones produced IL-4 following antigenic
stimulation. Five of 21 secreted IFNγ in addition, being thus considered
as TH0-type T cells in contrast to the 16 TH2-type clones. All CD81
T cell clones produced IFNγ, and seven of 11 also produced IL-4 after
nickel stimulation. A total of seven TC0- and four TC1-type nickel-
specific T cell clones were thus identified.
Nickel-specific CD8F T cell clones are only activated by living
APC and the metal needs to be constantly present in the
media The antigenic requirements for the presentation of NiSO4 to
the CD81 T cell clones were tested in both proliferation and cytotoxic
assays. As shown in Fig 3(a) for T cell clone 5C, pulsing of the APC
for 90 min at 37°C with NiSO4 was not sufficient to allow stimulation
of T cell proliferation. Moreover, fixed APC were not able to stimulate
T cell proliferation even when nickel was continuously present during
the assay (Fig 3b). This is in contrast to results previously obtained for
certain CD41 T cells (Moulon et al, 1995). A positive control (Fig 3e)
was performed in order to demonstrate that APC fixed by the same
method could present an antigen that did not require any processing
(peptide HA307–319) to a specifc T cell clone. Pulsing of target cells
with NiSO4 in the cytotoxic assay revealed that target cells could only
be lysed when nickel was present during the assay (Fig 3c), but not
when target cells were pulsed with NiSO4 and washed before addition
to the effector cells (Fig 3d). Both kinds of targets were, however,
lysed by the T cell clone in the presence of PHA.
The majority of the CD8F clones, but not clone L1.1, only
exhibit cytotoxic activities towards autologous EBV-B cell
lines To investigate the MHC restriction of the CD81 T cell clones,
cytotoxic assays were performed using the MHC-typed EBV-B cell
lines from the three donors as well as a donor-unrelated B cell line
(Sweig). Representative results shown in Fig 4 indicate that most of
the CD81 T cell clones exclusively lysed their respective autologous
targets in the presence of nickel, but none of the three other B cells
used as APC (e.g., when nickel was added, clone 5C was only able to
lyse autologous AE targets and clone 5K specifically lysed autologous
CM targets); however, one T cell clone, namely clone L1.1 from
donor IF, could lyse all of the tested targets in the presence of nickel.
All of the B cell lines tested to date (from 10 different donors)
were antigen-specifically lysed by clone L1.1 independently of MHC
haplotype (data not shown). These results thus raised the question
whether clone L1.1 was at all MHC restricted.
Clone L1.1 requires neither MHC class I nor MHC class II for
nickel-specific lysis In order to investigate the MHC requirements
for activation of the L1.1 CD81 T cell clone, two cell lines lacking
either MHC class I molecules (721.221 cells) or MHC class II molecules
(T2 cells) were used as target cells (Shimizu and DeMars, 1989;
Newcomb and Cresswell, 1993). As shown in Fig 5, both targets were
lysed either in the presence of nickel or in the presence of the lectin,
thereby indicating that neither MHC class I nor MHC class II
expression was required for activation of this T cell clone by nickel.
DISCUSSION
CHS has long been described as a typical delayed-type hypersensitvity
(DTH) reaction, differing from the latter only by the nature of the
inducing antigens, which in the case of CHS are compounds of low
molecular weight (Dupuis and Benezra, 1982 ) called haptens. Recent
studies conducted in different mouse models of CHS have documented
other differences between DTH and CHS. Thus, in contrast to DTH,
representing a typical TH1 CD41 T cell-mediated disease (Cher and
Mosmann, 1987), evidence is now accumulating that a major effector
role is played by CD81 T cells in mouse CHS. This has been suggested
by Gocinski and Tigelaar (1990) and has been recently confirmed by
different groups (Anderson et al, 1995; Bour et al, 1995). Moreover,
Xu et al (1996) have reported that CD81 effector T cells are producing
IFNγ (TC1 cells), whereas CD41 downregulator T cells belong to the
TH2-type, producing IL-4 and IL-10.
In humans, reports have also described the activation of CD81 T
cells, either as the major T cell population, e.g., in CHS reactions to
urushiol (Kalish, 1990) or to β-lactam antibiotics (Hertl et al, 1993),
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Table I. Cytokine production and CLA expression by nickel-
specific CD4F and CD8F T cell clones
Cytokine production (pg per ml)a
IL-4 IFNγ CLA expressionb
CD4 cells
Ni 4.13 812 1087 1
HSA.Ni 1.1 978 ,40 ndc
HSA.Ni 1.3 1165 ,40 nd
HSA.Ni 1.6 1076 ,40 nd
HSA.Ni 2.0 954 326 nd
HSA.Ni 2.2 1018 ,40 nd
HSA.Ni 2.4 1056 ,40 nd
HSA.Ni 2.5 796 ,40 nd
HSA.Ni 2.6 964 ,40 nd
HSA.Ni 2.7 1038 ,40 nd
HSA.Ni 2.8 1056 ,40 nd
HSA.Ni 2.9 256 44 nd
HSA.Ni 3.3 870 ,40 nd
HSA.Ni 3.4 998 ,40 nd
Ni 5A 37 103 nd
Ni 5D 736 336 nd
Ni 1C 761 ,40 nd
Ni 2C 344 ,40 nd
Ni 4B 712 ,40 nd
Ni 1H 784 ,40 nd
Ni 2L 1083 ,40 nd
CD8 cells
Ni L1.1 532 936 1
Ni a13 1296 1211 1
Ni b1 ,40 851 1
Ni b2 ,40 480 1
Ni b3 ,40 2159 1
Ni b5 222 2354 1
Ni b11 176 1423 1
Ni b12 580 891 1
Ni b15 ,40 561 1
Ni b17 490 2143 1
Ni b25 86 590 1
aCD41 or CD81 T cell clones were cultured with APC and 10–4 M NiSO4. After
48 h culture supernatants were used to measure IFNγ and IL-4 production. A cytokine
production ,40 pg per ml was observed in the absence of nickel.
bCLA staining was performed 1 wk after stimulation of the T cell clones by irradiated
PBMC, PHA, and IL2.
cNot determined.
or as a minor population, e.g., in CHS to anesthetics (Zanni et al,
1997). Another category of extremely potent contact sensitizers consists
of metals, with nickel representing the most common sensitizer in
humans (Basketter et al, 1993); however, although mentioned in
different studies (Silvennoinen-Kassinen et al, 1986; Bour et al, 1994;
Vollmer et al, 1997; Werfel et al, 1997), no detailed reports have been
published on nickel-activated CD81 T cells.
In this study we report the isolation and characterization of nickel-
specific CD81 T cells from the peripheral blood of human donors
allergic to nickel. In agreement with previous studies (Silvennoinen-
Kassinen et al, 1992, 1995), we have found that after a first in vitro
stimulation the majority of the T cell population is composed of CD41
cells, and CD81 T cells only constitute a minor population. After two
or three rounds of in vitro stimulation, however, the number of CD81
T cells increases and in some experiments constitutes the majority of
the T cells. Bour et al (1994) have also described a majority of CD81
T cells in nickel specific T cell lines without mentioning the time
point of the phenotypical analysis of the cell lines.
To perform a more detailed analysis of these CD81 nickel-specific
T cells, we have isolated T cell clones from three donors. Again, as
previously described (Vollmer et al, 1997; Werfel et al, 1997), CD41
T cell clones constitute the major T cell population; however, CD81
T cell clones could be obtained from each of the allergic donors.
Werfel et al (1997) compared the number of CD81 and CD41 clones
isolated from blood versus skin and found 33% of nickel-reactive CD81
clones in the blood versus 15% in the skin. The fact that the CD81
Figure 2. Nickel-specific CD8F T cell clones display both proliferating
capacities and specific cytotoxic activities. The two representative T cell
clones L1.1 and 3.3, isolated from donor IF, are shown. (a) CD4, CD8, and
αβTcR phenotypes were investigated by fluorescence-activated cell sorter
analysis. Black histograms represent the staining with the appropriate antibody
and white histograms represent the isotypic control. (b) Proliferative responses
to nickel in the presence of autologous EBV-B cells were determined by
incorporation of [3H]thymidine in triplicate and are expressed in cpm.
Stimulation with other metals such as Cr, Co, Cu, Pd, and Zn was also tested.
The horizontal bold line in each figure represents the proliferation observed in
the absence of metal salts. (c) Cytotoxic activities were determined in a 51Cr-
release assay and data are expressed as the percentage of specific lysis of
autologous EBV-B cell targets in the absence or in the presence of nickel or
phytohaemaglutinin at different effector/target ratios.
clones characterized in our study express the skin-selective homing
receptor CLA (Picker et al, 1991) strongly suggests that, although
isolated from the peripheral blood, these T cells might be able to
migrate to the skin and become an important cellular component of
CHS reactions. It has been reported that the nickel-dependent
circulating memory CD31 T cells are mainly confined to the CLA1
subset in patients allergic to this metal (Santamaria Babi et al, 1995).
We extend those results by showing that nickel-specific CD81 T cells
can express CLA.
In the past, human nickel-specific CD41 T cells have been exten-
sively characterized in terms of proliferation, processing requirements,
and cytokine production. As previously shown for CD41 cells, CD81
T cells are also able to proliferate to nickel presented by autologous
APC. CD41 T cell clones have been shown to cross-react to different
other metals, such as Pd and Cu (Moulon et al, 1995; Pistoor et al,
1995). We show here that this also holds true for CD81 T cells, in
that at least one of the T cell clones cross-reacts to Pd. Concerning
their processing requirements, nickel-specific CD81 T cells seem to
be less heterogeneous than CD41 T cells (Moulon et al, 1995), as they
are only able to be activated by living APC and in the constant
presence of the antigen. Nickel-specific CD81 T cell clones thus differ
from human β-lactam-specific CD81 cells that are able to recognize
pulsed APC (Hertl et al, 1993). They are also different in their
364 MOULON ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Figure 3. Nickel-specific CD8F T cell clones require the constant presence of nickel and living APC for activation. (a–b) Proliferative responses to
nickel in the presence of autologous EBV-B cells were determined by incorporation of [3H]thymidine in triplicate and are expressed in cpm 6 SD. NiSO4 was
added to the well (1Ni) or APC were pulsed with NiSO4 and washed as indicated in Materials and Methods. APC were either irradiated (a) or fixed (b) and
representative data are shown for clone 5C from donor AE. (c–d) Cytotoxic activities were determined in a 51Cr-release assay and representative data, expressed as
the percentage of specific lysis, are shown for clone L1.1 from donor IF. Autologous EBV-B cells were used as targets in the presence of either nickel or PHA at
different effector/target ratios during the 4 h assay (c) or were pulsed with NiSO4 and then washed (d) before the incubation with T cells. (e) Proliferative response
of the DR1-restricted clone 12F to 25 µg per ml of the peptide HA309–319 (6 HA) in the presence of DR1 homozygous EBV-B cells was determined by
incorporation of [3H]thymidine in triplicate and is expressed in cpm 6 SD. APC were either irradiated or fixed.
Figure 4. The majority of the CD8F clones, but not clone L1.1,
only exhibit cytotoxic activities towards autologous EBV-B cell lines.
Cytotoxic activities of the CD81 T cell clones were determined in a 51Cr-
release assay using autologous (AE-, CM-, and IF-B cells) and allogeneic (Sweig
B cells) EBV-B cell lines as targets. Representative experiments are shown for
the three T cell clones, 5C from donor AE, 5K from donor CM, and L1.1
from donor IF. Data are expressed as the percentage of specific lysis of EBV-B
cell targets in the absence or in the presence of nickel at different effector/
target ratios.
mechanism of activation from urushiol-specific T cell clones that were
shown to be processing independent (Kalish et al, 1994). Our data
suggest that either the formation of the antigenic epitopes recognized
by metal-specific CD81 clones requires the entry of nickel into the
Figure 5. The clone L1.1 is neither MHC class I nor MHC class II
restricted. Cytotoxic activities of the CD81 T cell clone L1.1 were determined
in a 51Cr-release assay using MHC class I-(721.221) and class II-(T2) deficient
cell lines as targets. Representative data are shown and are expressed as the
percentage of specific lysis of targets in the absence (empty symbols) or in the
presence of nickel (black symbols) or phytohaemaglutinin (dotted line) at different
effector/target ratios.
cells, or the structures binding nickel have a low affinity for the metal
and that these antigenic structures are abolished by fixation or washing
of the APC.
Although CHS is thought to be partially mediated by cytokines
produced by primed T cells, the type of cytokine production by
hapten-specific T cells is still a matter of debate. In this study we have
found that nickel-specific CD81 T cell clones differ from their CD41
counterparts by the nature of the cytokines produced after antigenic
stimulation. While the CD81 cells are all producing IFNγ, in some
cases in conjunction with IL-4, the CD41 cells are always secreting
IL-4 and for some clones also IFNγ. Some of the tested CD41 T cell
clones were induced using nickel in the form of HSA-Ni and we
observed a polarized TH2 pattern of these T cells in response to
NiSO4. The fact that we also obtained TH2-type T cells from another
donor while using the conventional NiSO4 as antigen, suggests,
however, that there is no major difference in cytokine production
depending of the source of nickel used for the induction of nickel-
specific T cell clones. We thus observe that nickel-specific CD81 T
cells tend to exhibit a TC0/TC1-type, in contrast to nickel-specific
CD41 T cells that belong to the TH0/TH2 subset. Our results
concerning cytokine production by nickel-specific CD41 and CD81
T cells, thus add more conflicting results to the already contradictory
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findings reported in previous studies (Kapsenberg et al, 1992; Probst
et al, 1995; Breit et al, 1996; Werfel et al, 1997). While Kapsenberg
et al (1992) reported a TH0/TH1 polarized cytokine pattern of blood
nickel-specific CD41 cells, Probst et al (1995) described a TH0/TH2
oriented cytokine production by cutaneous nickel-specific CD41 cells.
Werfel et al (1997), studying both CD4 and CD8 subsets, observed a
dichotomy of blood- and skin-derived IL-4 producing nickel-specific
T cells: in contrast to blood-derived T cell clones, the majority of
skin-derived T lymphocytes had a T0/T2 cytokine production pattern,
and the type of cytokine produced was independent of the CD4/CD8
phenotype. From all of these studies we conclude that cytokine
production by nickel-specific cells cannot be easily classified in type 1
versus type 2 subsets, depending on the blood or cutaneous origins or
on the CD4 versus CD8 phenotype of the metal-specifc T cells. It
seems to be established now, however, that both IL-4 and IFNγ are
involved in the course of CHS reactions (Szepietowski et al, 1997).
In murine CHS reactions, Xu et al (1996) have reported that IFNγ-
producing CD81 T cells are effectors of CHS, whereas IL-4 and
IL-10 producing CD41 T cells are negative regulators of the disease.
In the light of these data, more experiments are now required to clarify
the nature of the cytokines, as well as the role of the T cell subsets,
involved in the different phases of human CHS to nickel.
Finally, it is relevant to discuss the capacity of CD81 nickel-specific
T cells to induce the lysis of target cells after different stimulations, as
this effector function is one of the most characteristic for CD81 T
cells. We have investigated the cytolytic potential in nickel-specific
CD81 T cell clones using a nonantigen-specific stimulus in a lectin-
mediated assay, and have found that all CD81 T cell clones effectively
lyse target cells in the presence of PHA. It is very important to notice
that most of the in vitro protocols employed to culture and clone
human T cells use PHA stimulation and addition of IL-2 for T cell
expansion. We have regularly had problems in cultivating the T cell
lines containing a high proportion of CD81 T cells, possibly due to a
cytotoxic activity of the T cells towards their T cell counterparts in
the presence of PHA. This observation might explain the preferential
isolation of CD41 T cell clones from nickel-allergic donors.
With this report, we have extended the list of human hapten-specific
T cells having a cytotoxic potential in a lectin-mediated assay (Kalish,
1990; Hertl et al, 1993); however, in contrast to these previous studies,
nickel-specific CD81 T cell clones are also able to lyse target cells
following an antigen-specific stimulation. These in vitro data, showing
a nickel-dependent cytotoxic activity of CD81 T cell clones, suggest
a similar potential of the CD81 nickel-specific T cells in vivo in the
course of the CHS to nickel. Most of the CD81 T cell clones appear
to be MHC restricted, and exhibit cytotoxic activity only towards
autologous targets. The nature of the antigenic determinants recognized
by those T cells, however, remains to be determined. In addition, we
describe another type of nickel-specific CD81 T cell. The one T cell
clone L1.1, characterized in detail in this study, lyses diverse target
cells only in the presence of the antigen nickel, but independently of
the expression of either MHC class I or MHC class II molecules. The
MHC class I- or II-deficient cells used in our study are not expressing
CD1 molecules, and thereby exclude the presentation of nickel by
CD1 molecules. The mechanism of activation of this CD81 T cell
clone remains unidentified. The fact that this T cell clone only lyses
target cells in the presence of nickel suggests that this is not a clear
natural killer-like activity. We cannot exclude that this would be the
result of unmasking a natural killer receptor by addition of nickel;
however, this T cell clone does not express any so far identified natural
killer receptors (data not shown). This metal-specific CD81 T cell
clone, however, exhibits some similarities to other CD81 T cells
induced by nonpeptidic antigens. Recently, a number of reports
have indicated that not only proteins, but also lipids and glycolipids
(Beckman et al, 1994; Branch Moody et al, 1997), phosphorylated
metabolites (De Libero, 1997), and maybe carbohydrates (Corinti et al,
1997) can activate human T cells. In some cases this activation is
mediated by CD1 molecules, but other mechanisms independent of
MHC class I, class I-like, or class II molecules have been suggested
and are still a subject of intensive investigation (Morita et al, 1995;
Corinti et al, 1997; De Libero, 1997). We report here that metal-
induced activation of human CD81 T cells might, for some of the T
cell clones, also be mediated by so far unindentified mechanisms.
In conclusion, we have shown here that nickel-specific CD81 T
cell clones are present in the peripheral blood of nickel-allergic donors.
Although constituting only a minor subpopulation of the nickel-
specific T cells in donors allergic to nickel, these CD81 lymphocytes
clearly have effector functions, such as cytotoxic activity and cytokine
production, activated in the presence of the specific metal. Furthermore,
different subsets can be distinguished on the basis of the MHC
requirement for nickel recognition, but both of them seem to have
the capacity to migrate to the skin, due to CLA antigen expression.
Our data thus suggest that nickel-specific CD81 cells are involved in
CHS reactions, and future investigation will hopefully lead to a better
understanding of the role of these CD81 cells in the pathogenesis of
human nickel contact dermatitis.
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